Global Secondary Progressive Multiple Sclerosis Drug Market Research Report 2019

Table of Contents

Executive Summary

1 Secondary Progressive Multiple Sclerosis Drug Market Overview

• 1.1 Product Overview and Scope of Secondary Progressive Multiple Sclerosis Drug
• 1.2 Secondary Progressive Multiple Sclerosis Drug Segment by Type
  • 1.2.1 Global Secondary Progressive Multiple Sclerosis Drug Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Inebilizumab
  • 1.2.3 GLX-1112
  • 1.2.4 DC-TAB
  • 1.2.5 Etomoxir
  • 1.2.6 IB-MS
  • 1.2.7 Others
• 1.3 Secondary Progressive Multiple Sclerosis Drug Segment by Application
  • 1.3.1 Secondary Progressive Multiple Sclerosis Drug Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.3 Global Secondary Progressive Multiple Sclerosis Drug Market by Region
  • 1.3.1 Global Secondary Progressive Multiple Sclerosis Drug Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Secondary Progressive Multiple Sclerosis Drug Market Size
  • 1.4.1 Global Secondary Progressive Multiple Sclerosis Drug Revenue (2014-2025)
  • 1.4.2 Global Secondary Progressive Multiple Sclerosis Drug Production (2014-2025)

2 Global Secondary Progressive Multiple Sclerosis Drug Market Competition by Manufacturers

• 2.1 Global Secondary Progressive Multiple Sclerosis Drug Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Secondary Progressive Multiple Sclerosis Drug Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Secondary Progressive Multiple Sclerosis Drug Production Sites, Area Served, Product Types
• 2.5 Secondary Progressive Multiple Sclerosis Drug Market Competitive Situation and Trends
  • 2.5.1 Secondary Progressive Multiple Sclerosis Drug Market Concentration Rate
  • 2.5.2 Secondary Progressive Multiple Sclerosis Drug Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Secondary Progressive Multiple Sclerosis Drug Production Market Share by Regions

• 3.1 Global Secondary Progressive Multiple Sclerosis Drug Production Market Share by Regions
• 3.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share by Regions (2014-2019)
• 3.3 Global Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Secondary Progressive Multiple Sclerosis Drug Production
  • 3.4.1 North America Secondary Progressive Multiple Sclerosis Drug Production Growth Rate (2014-2019)
  • 3.4.2 North America Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Secondary Progressive Multiple Sclerosis Drug Production
  • 3.5.1 Europe Secondary Progressive Multiple Sclerosis Drug Production Growth Rate (2014-2019)
  • 3.5.2 Europe Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Secondary Progressive Multiple Sclerosis Drug Production (2014-2019)
  • 3.6.1 China Secondary Progressive Multiple Sclerosis Drug Production Growth Rate (2014-2019)
  • 3.6.2 China Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Secondary Progressive Multiple Sclerosis Drug Production (2014-2019)
  • 3.7.1 Japan Secondary Progressive Multiple Sclerosis Drug Production Growth Rate (2014-2019)
  • 3.7.2 Japan Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Secondary Progressive Multiple Sclerosis Drug Consumption by Regions

• 4.1 Global Secondary Progressive Multiple Sclerosis Drug Consumption by Regions
• 4.2 North America Secondary Progressive Multiple Sclerosis Drug Consumption (2014-2019)
• 4.3 Europe Secondary Progressive Multiple Sclerosis Drug Consumption (2014-2019)
• 4.4 China Secondary Progressive Multiple Sclerosis Drug Consumption (2014-2019)
• 4.5 Japan Secondary Progressive Multiple Sclerosis Drug Consumption (2014-2019)

5 Global Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price Trend by Type

• 5.1 Global Secondary Progressive Multiple Sclerosis Drug Production Market Share by Type (2014-2019)
• 5.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share by Type (2014-2019)
• 5.3 Global Secondary Progressive Multiple Sclerosis Drug Price by Type (2014-2019)
• 5.4 Global Secondary Progressive Multiple Sclerosis Drug Production Growth by Type (2014-2019)

6 Global Secondary Progressive Multiple Sclerosis Drug Market Analysis by Applications

• 6.1 Global Secondary Progressive Multiple Sclerosis Drug Consumption Market Share by Application (2014-2019)
• 6.2 Global Secondary Progressive Multiple Sclerosis Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Secondary Progressive Multiple Sclerosis Drug Business

• 7.1 AB Science SA
  • 7.1.1 AB Science SA Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.1.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.1.3 AB Science SA Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Actelion Ltd
  • 7.2.1 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.2.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.2.3 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biogen, Inc.
  • 7.3.1 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.3.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.3.3 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 F. Hoffmann-La Roche Ltd.
  • 7.4.1 F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.4.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.4.3 F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Genzyme Corporation
  • 7.5.1 Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.5.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.5.3 Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Glialogix, Inc.
  • 7.6.1 Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.6.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.6.3 Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Immune Response BioPharma, Inc.
  • 7.7.1 Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.7.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.7.3 Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Innate Immunotherapeutics Ltd
  • 7.8.1 Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.8.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.8.3 Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Kyorin Pharmaceutical Co., Ltd.
  • 7.9.1 Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.9.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.9.3 Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Mallinckrodt Plc
  • 7.10.1 Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Production Sites and Area Served
  • 7.10.2 Secondary Progressive Multiple Sclerosis Drug Product Introduction, Application and Specification
  • 7.10.3 Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 MedDay SA
• 7.12 MedImmune, LLC
• 7.13 Merck KGaA
• 7.14 Meta-IQ ApS
• 7.15 Novartis AG
• 7.16 Opexa Therapeutics, Inc.
• 7.17 Xenetic Biosciences (UK) Limited

8 Secondary Progressive Multiple Sclerosis Drug Manufacturing Cost Analysis

• 8.1 Secondary Progressive Multiple Sclerosis Drug Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Secondary Progressive Multiple Sclerosis Drug
• 8.4 Secondary Progressive Multiple Sclerosis Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Secondary Progressive Multiple Sclerosis Drug Distributors List
• 9.3 Secondary Progressive Multiple Sclerosis Drug Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Secondary Progressive Multiple Sclerosis Drug Market Forecast

• 11.1 Global Secondary Progressive Multiple Sclerosis Drug Production, Revenue Forecast
  • 11.1.1 Global Secondary Progressive Multiple Sclerosis Drug Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Secondary Progressive Multiple Sclerosis Drug Price and Trend Forecast (2019-2025)
• 11.2 Global Secondary Progressive Multiple Sclerosis Drug Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Secondary Progressive Multiple Sclerosis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Secondary Progressive Multiple Sclerosis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Secondary Progressive Multiple Sclerosis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Secondary Progressive Multiple Sclerosis Drug Production, Revenue Forecast (2019-2025)
• 11.3 Global Secondary Progressive Multiple Sclerosis Drug Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Secondary Progressive Multiple Sclerosis Drug Consumption Forecast (2019-2025)
  • 11.3.2 Europe Secondary Progressive Multiple Sclerosis Drug Consumption Forecast (2019-2025)
  • 11.3.3 China Secondary Progressive Multiple Sclerosis Drug Consumption Forecast (2019-2025)
  • 11.3.4 Japan Secondary Progressive Multiple Sclerosis Drug Consumption Forecast (2019-2025)
• 11.4 Global Secondary Progressive Multiple Sclerosis Drug Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Secondary Progressive Multiple Sclerosis Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List